U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710183) titled 'Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients' on July 13.
Brief Summary: Patients with end-stage renal disease (ESRD) on maintenance hemodialysis experience chronic systemic inflammation, oxidative stress, and dyslipidemia, which together drive much of the excess cardiovascular morbidity and mortality seen in this population. Pumpkin seed oil is a nutraceutical rich in polyunsaturated fatty acids, phytosterols,and tocopherols, with documented antioxidant, anti-inflammatory, and antihyperlipidemic properties in preclinical and limited clinical studies. This study investigates the potential role of pumpkin seed oil as...